Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
meeting source : Www.celyad.com save search
Celyad Oncology Presents Preclinical Data on Allogeneic CAR T Therapy Program and Highlights KEYNOTE-B79 Clinical Trial Design at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting
Published: 2021-11-12 (Crawled : 12:15) - celyad.com
CYAD | $0.47 -12.49% 49K
|
Health Technology
|
| O: -0.74%
H: 0.0%
C: 0.0%
immunotherapy therapy cancer trial car-t preclinical pre-clinical designation
Celyad Oncology to Present Updates from Allogeneic and Autologous CAR T Programs at 63rd ASH Annual Meeting and Exposition
Published: 2021-11-04 (Crawled : 13:00) - celyad.com
CYAD | $0.47 -12.49% 49K
|
Health Technology
|
| O: -2.78%
H: 2.38%
C: -0.95%
car-t
Celyad Oncology to Present New Data on Allogeneic CAR T Therapy Program at the Society for Immunotherapy of Cancer Annual Meeting
Published: 2021-10-01 (Crawled : 12:15) - celyad.com
CYAD | $0.47 -12.49% 49K
|
Health Technology
|
| O: 3.66%
H: 0.0%
C: -4.47%
immunotherapy therapy cancer car-t
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | News | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.